The use of digital pathology and image analysis in clinical trials

• Váldodahkkit: Robert Pell (Dahkki), Karin Oien (Dahkki), Max Robinson (Dahkki), Helen Pitman (Dahkki), Nasir Rajpoot (Dahkki), Jens Rittscher (Dahkki), David Snead (Dahkki), Clare Verrill (Dahkki), on behalf of the UK National Cancer Research Institute (NCRI) (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2019-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Digital pathology and image analysis potentially provide greater accuracy, reproducibility and standardisation of pathology‐based trial entry criteria and endpoints, alongside extracting new insights from both existing and novel features. Image analysis has great potential to identify, extr...